Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Milatovic

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Antimicrobial Chemotherapy|February 7, 2001
Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolatesF J Schmitz, A Krey, R Sadurski, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 12, 2001
Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniaeF J Schmitz, A Fisher, M Boos, et al.
The Journal of Antimicrobial Chemotherapy|July 7, 2000
In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureusF J Schmitz, A C Fluit, D Milatovic, et al.
Biomedizinische Technik. Biomedical Engineering|January 1, 1997
[Therapy of peri-implant inflammation with the CO2 swift laser system. An in vitro and in vivo study]H Deppe, H H Horch, T Hiermer, et al.
Journal of Clinical Microbiology|October 4, 2000
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotypingS Brisse, D Milatovic, A C Fluit, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 5, 2002
Pharmacokinetics and absolute bioavailability of sitafloxacin, a new fluoroquinolone antibiotic, in healthy male and female Caucasian subjectsJ O'Grady, A Briggs, S Atarashi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 29, 2001
Carriage of gram-negative bacilli in young Brazilian children with community-acquired pneumoniaB Wolf, L C Rey, L B Moreira, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteinsS Brisse, D Milatovic, A C Fluit, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2000
Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae colonizing children with community-acquired pneumonia and children attending day-care centres in Fortaleza, BrazilB Wolf, L C Rey, S Brisse, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolonesS Brisse, A C Fluit, U Wagner, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|February 7, 2001
Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolatesF J Schmitz, A Krey, R Sadurski, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 12, 2001
Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniaeF J Schmitz, A Fisher, M Boos, et al.
The Journal of Antimicrobial Chemotherapy|July 7, 2000
In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureusF J Schmitz, A C Fluit, D Milatovic, et al.
Biomedizinische Technik. Biomedical Engineering|January 1, 1997
[Therapy of peri-implant inflammation with the CO2 swift laser system. An in vitro and in vivo study]H Deppe, H H Horch, T Hiermer, et al.
Journal of Clinical Microbiology|October 4, 2000
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotypingS Brisse, D Milatovic, A C Fluit, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 5, 2002
Pharmacokinetics and absolute bioavailability of sitafloxacin, a new fluoroquinolone antibiotic, in healthy male and female Caucasian subjectsJ O'Grady, A Briggs, S Atarashi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 29, 2001
Carriage of gram-negative bacilli in young Brazilian children with community-acquired pneumoniaB Wolf, L C Rey, L B Moreira, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteinsS Brisse, D Milatovic, A C Fluit, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2000
Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae colonizing children with community-acquired pneumonia and children attending day-care centres in Fortaleza, BrazilB Wolf, L C Rey, S Brisse, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolonesS Brisse, A C Fluit, U Wagner, et al.
Pageof 9